MRM - Kewajiban jangka dawa marang modal MEDIROM Corp

Simbol lan logo merek MEDIROM Corp (MRM)

Long-term debt-to-equity demonstrates stability for MEDIROM (MRM), Japan's largest relaxation network, where customer habits generate a steady cash flow. The current value of this metric is 0.00, confirming the strategic shift toward digital transformation and the implementation of AI platforms within Re.Ra.Ku. Efficiency is maintained by outsourcing IT infrastructure to external vendors while maintaining strict control over service quality.

Rasio utang jangka dawa marang ekuitas: medirom.co.jp (MRM) kanggo 04.07.2022 - 28.10.2026
Barang utama MEDIROM Healthcare Group Inc

Assessing financial stability requires an analysis of the ratio between long-term liabilities and equity. This metric measures the proportion of loans with a maturity of more than one year, determining the company's degree of dependence on external borrowing. The dynamics of long-term debt to equity allow for the real-time tracking of structural shifts in the balance sheet. For MEDIROM (MRM), this balance is critical when scaling its network of premium relaxation centers. The stability of this indicator confirms the ability of the Japanese market leader to maintain benchmark service without an excessive credit load.

Pesaing utama

Koefisien utang jangka dawa marang modal HCA Holdings|Tenet - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Fresenius Medical (FMS)|Utang jangka dawa marang modal SOLV (Solventum Corporation)|EHC - Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas Universal Health Services Corp UHS|DVA: Rasio silihan jangka dawa marang modal|RDNT (RadNet Corp) - Utang jangka dawa marang ekuitas|Option Care Corp (OPCH) - Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang modal SGRY (Surgery Partners, Inc.)|Kewajiban jangka dawa marang modal PINC|Utang jangka dawa marang ekuitas National Vision EYE|Rasio utang jangka dawa marang modal Progyny Inc PGNY|Rasio utang jangka dawa marang ekuitas Ardent Health Partners Inc (ARDT)|Select Medical Inc. - Rasio silihan jangka dawa marang modal|ASTH: Utang jangka dawa marang ekuitas|MD - Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang modal USPH|Pennant Group (PNTG) - Kewajiban jangka dawa marang modal|Utang jangka dawa marang modal Organogenesis Inc. (ORGO)|Rasio utang jangka dawa marang modal Nutex Health Hospitals|AUNA (Auna SA) - Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal SBC (SBC Medical Group Holdings Inc.)|Utang jangka dawa marang ekuitas Evolus|CHS - Koefisien utang jangka dawa marang modal|SKIN (Beauty Health) - Utang jangka dawa marang ekuitas|MDWD: Kewajiban jangka dawa marang modal|BTMD (biote Corp.) - Utang jangka dawa marang ekuitas|JYNT (thejoint.com) - Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang ekuitas DCGO|Rasio utang jangka dawa marang ekuitas PIII|Gain Therapeutics, Inc. (GANX) - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal EUDA (euda.com)|Basel Medical Group Ltd - Utang jangka dawa marang ekuitas|CLGN - Rasio utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas Cuprina Holdings CUPR|CCM: Rasio silihan jangka dawa marang modal|Utang jangka dawa marang ekuitas American Shared Hospital Services, Inc. AMS|Avalon GloboCare Corp. (ALBT) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal DHAI (DIH Holding US, Inc.)|Kewajiban jangka dawa marang modal carmellcosmetics.com|Utang jangka dawa marang modal NIVF|Utang jangka dawa marang modal atipt.com ATIP|Rasio utang jangka dawa marang ekuitas CareMax Medical Group (CMAX)|Kindly Health - Rasio silihan jangka dawa marang modal|MODV: Utang jangka dawa marang ekuitas|NVOS - Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang modal SSY|BACK (IMAC Holdings Inc) - Kewajiban jangka dawa marang modal